Related to GVK and Excel PharmaStudies Join Forces to Help Sponsors Conduct Clinical Trials in India and China

• Novartis Offers 28% More for Increased Control over India Operations
  
• Pfizer Ups Bid to Roughly $172.8M for an Increased Stake in Indian Operations
  
• Sanofi Pasteur Picks Up Indian Vaccine Firm through Purchase of ShanH
  
• Bruker Sets Up Mass Spectrometry Joint Venture in India
  
• Evotec Buys 70% of Indian Drug Discovery Services Firm for Over $4M
  
• S-Evans Biosciences Gains Chinese Rights to Cryo-Cell’s Menstrual Stem Cell Technology
  
• Wellcome Trust and Merck Set Up JV to Focus on Vaccines for Developing Nations
  
• GSK Furthers Interest in China through Pediatric Vaccines JV with Initial $32M Investment
  
• Merck KGaA and Lonza Separately Acquire Indian Bioscience Companies
  
• Simcere Fortifies Stake in Chinese H1N1 Vaccine Firm to Over 50%
  
• Novartis to Invest $1.25B in Two New Facilities in China
  
• Novartis to Buy 85% of Chinese Vaccines Company for $125M
  
• Wanbang to Advance D-Pharm’s Late-Stage Stroke Therapy in China
  
• Millipore Acquires Remaining Ownership of India JV
  
• Merck Serono to Invest More than €150M in R&D Center in China
  
• Gilead and GlaxoSmithKline Divvy Up Commercialization of Viread® for HBV in Key Asian Countries
  
• Sinovac Expands Vaccine Capabilities with New JV
  
• Meda In-Licenses Commercial Rights to EpiCept’s AML Therapy for $3M
  
• LFB Licenses Thallion’s Early-Stage Candidate for Treating STEC Infections
  
• Beijing Pioneer to Provide Olink’s Duolink Product Line in China